Ads
related to: chronic lymphoma leukemia prognosis- Dosing Information
View Recommended Dosing Schedules
For This Treatment Option.
- Safety & Side Effects
Read Important Safety And Possible
Side Effects Information.
- Cell Therapy 360®
Discuss With Your Doctor
And Learn About Unique Treatment
- How This Treatment Works
Get Info On Lymphoma
Treatment & See How It Works
- Dosing Information
Search results
Results from the WOW.Com Content Network
Five account for nearly three out of four patients with non-Hodgkin lymphoma: [3] Diffuse large B-cell lymphoma (DLBCL) [4] Follicular lymphoma; Marginal zone B-cell lymphoma (MZL) or mucosa-associated lymphatic tissue lymphoma (MALT) Small lymphocytic lymphoma (SLL, also known as chronic lymphocytic leukemia, CLL) Mantle cell lymphoma (MCL)
Diffuse large B-cell lymphoma (DLBCL) is a cancer of B cells, a type of lymphocyte that is responsible for producing antibodies.It is the most common form of non-Hodgkin lymphoma among adults, [1] with an annual incidence of 7–8 cases per 100,000 people per year in the US and UK.
T-cell lymphoma is a rare form of cancerous lymphoma affecting T-cells. [1] Lymphoma arises mainly from the uncontrolled proliferation of T-cells and can become cancerous. [2] T-cell lymphoma is categorized under Non-Hodgkin lymphoma (NHL) and represents less than 15% of all Non-Hodgkin's diseases in the category. [3]
Mast cell leukemia is an extremely aggressive subtype of acute myeloid leukemia that usually occurs de novo but can, rarely, evolve from transformation of chronic myeloid leukemia into the more aggressive acute myeloid leukemia. In a small proportion of cases, acute mast cell leukemia may evolve from a more progressive form of systemic ...
B-cell prolymphocytic leukemia, referred to as B-PLL, is a rare blood cancer.It is a more aggressive, but still treatable, form of leukemia.. Specifically, B-PLL is a prolymphocytic leukemia (PLL) that affects prolymphocytes – immature forms of B-lymphocytes and T-lymphocytes – in the peripheral blood, bone marrow, and spleen.
Leukemia cutis is the infiltration of neoplastic leukocytes or their precursors into the skin resulting in clinically identifiable cutaneous lesions. [1] This condition may be contrasted with leukemids, which are skin lesions that occur with leukemia, but which are not related to leukemic cell infiltration.
Ads
related to: chronic lymphoma leukemia prognosis